GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
07 Nov 2025 07:00 AM
RNS
Transaction in Own Shares
06 Nov 2025 07:00 AM
RNS
Transaction in Own Shares
05 Nov 2025 07:00 AM
RNS
Transaction in Own Shares
04 Nov 2025 07:00 AM
RNS
Transaction in Own Shares
03 Nov 2025 03:00 PM
RNS
Total Voting Rights
03 Nov 2025 07:00 AM
RNS
Transaction in Own Shares
31 Oct 2025 07:00 AM
RNS
Transaction in Own Shares
30 Oct 2025 03:30 PM
RNS
Director/PDMR Shareholding
30 Oct 2025 07:00 AM
RNS
Transaction in Own Shares
29 Oct 2025 07:05 AM
RNS
Transaction in Own Shares
29 Oct 2025 07:00 AM
RNS
3rd Quarter Results
28 Oct 2025 07:00 AM
RNS
Transaction in Own Shares
28 Oct 2025 07:00 AM
RNS
GSK ADC gets orphan drug designation in the EU
27 Oct 2025 07:00 AM
RNS
Transaction in Own Shares
24 Oct 2025 07:00 AM
RNS
Blenrep approved by US FDA in multiple myeloma
24 Oct 2025 07:00 AM
RNS
Transaction in Own Shares
23 Oct 2025 07:00 AM
RNS
Transaction in Own Shares
22 Oct 2025 07:05 AM
RNS
Positive data for low carbon version Ventolin MDI
22 Oct 2025 07:00 AM
RNS
Transaction in Own Shares
22 Oct 2025 07:00 AM
RNS
Latozinemab data read out
21 Oct 2025 07:05 AM
RNS
Positive CHMP Opinion for GSK on Shingrix PFS
21 Oct 2025 07:00 AM
RNS
Transaction in Own Shares
21 Oct 2025 07:00 AM
RNS
GSK share positive Ph3 data on tebipenem HBr
20 Oct 2025 07:00 AM
RNS
Transaction in Own Shares
17 Oct 2025 07:00 AM
RNS
Transaction in Own Shares
16 Oct 2025 03:30 PM
RNS
Director/PDMR Shareholding
16 Oct 2025 07:00 AM
RNS
Transaction in Own Shares
15 Oct 2025 03:30 PM
RNS
Director/PDMR Shareholding
15 Oct 2025 07:00 AM
RNS
Transaction in Own Shares
14 Oct 2025 07:00 AM
RNS
GSK receives expanded Shingrix approval in China
14 Oct 2025 07:00 AM
RNS
Transaction in Own Shares
13 Oct 2025 03:30 PM
RNS
Director/PDMR Shareholding
13 Oct 2025 07:00 AM
RNS
Transaction in Own Shares
10 Oct 2025 03:30 PM
RNS
Director/PDMR Shareholding
10 Oct 2025 07:00 AM
RNS
Transaction in Own Shares
09 Oct 2025 07:00 AM
RNS
Transaction in Own Shares
08 Oct 2025 07:00 AM
RNS
Transaction in Own Shares
07 Oct 2025 07:00 AM
RNS
Transaction in Own Shares
06 Oct 2025 07:00 AM
RNS
Transaction in Own Shares
03 Oct 2025 07:00 AM
RNS
Transaction in Own Shares
02 Oct 2025 07:00 AM
RNS
Transaction in Own Shares
01 Oct 2025 03:00 PM
RNS
Total Voting Rights
01 Oct 2025 07:00 AM
RNS
Transaction in Own Shares
30 Sep 2025 07:00 AM
RNS
GSK - third tranche of share buyback programme
29 Sep 2025 07:00 AM
RNS
GSK appoints CEO designate
22 Sep 2025 03:30 PM
RNS
Director/PDMR Shareholding
19 Sep 2025 07:00 AM
RNS
Transaction in Own Shares
18 Sep 2025 07:00 AM
RNS
Transaction in Own Shares
17 Sep 2025 07:00 AM
RNS
GSK US Investment Announcement
17 Sep 2025 07:00 AM
RNS
Transaction in Own Shares

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

GSK share price launched at 346p in 1989. 

UK 100

Latest directors dealings